<DOC>
	<DOCNO>NCT01080859</DOCNO>
	<brief_summary>The purpose trial evaluate completeness strut coverage vessel wall response ( strut malapposition , neoin-timal formation ) bio-active-stent ( BAS ) versus ever-olimus-eluting stent ( EES ) implant treatment culprit lesion acute coronary syndrome .</brief_summary>
	<brief_title>Vessel Wall Response Bio-Active-stent Everolimus-Eluting Stent Assessed By Optical Coherence Tomography</brief_title>
	<detailed_description>A prospective , randomize control study compare coverage BAS EES implant acute coronary syndrome . Clinical follow-up 1 , 6 , 12 18 month . OCT analysis time 6 8 month follow-up .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Patient â‰¥ 18 year old ; The patient present acute coronary syndrome , accord hospital routine practice , eligible percutaneous coronary intervention ; Patient patient 's legal representative inform nature study provide write informed consent approve Institutional Ethics Committee respective clinical site . Lesions coronary artery bypass graft Left main disease Killip class IIIIV Allergy aspirin / thienopyridine Patient anticoagulation therapy No suitable anatomy OCT scan Ostial lesion Tortuosity anatomy Very distal lesion Vessel size &gt; 3.75 mm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>titanium</keyword>
	<keyword>everolimus</keyword>
	<keyword>oct</keyword>
	<keyword>acute coronary syndrome</keyword>
	<keyword>stent</keyword>
	<keyword>pci</keyword>
	<keyword>stenting</keyword>
</DOC>